Unither Pharmaceuticals   Report issue

For profit Phase 1 Phase 3
Founded: Amiens France (1993)

Organization Overview

First Clinical Trial
2000
NCT00034372
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Unither Pharmaceuticals, France | Unither Virology

Active Ingredients

Drugs in Phase 3 Trials (3)

acetaminophen (tylenol) (4 trials)

nefopam (2 trials)

oregovomab (4 trials)

Drugs in Phase 1 Trials (1)

uv-4b (1 trial)

Drugs in Other Trials (1)

vitamin a (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 3)

Infections (Phase 1)

Ovarian Neoplasms (Phase 3)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 5